FDA-approved oral semaglutide The FDA has approved oral semaglutide (Rybelsus) for type 2 diabetes, and in early 2026, oral semaglutide received FDA approval for weight loss as well
This creates recurring revenue quality similar to SaaS businesses, justifying higher multiples for the winners
Look for ongoing medical oversight
Ivy Rx offers a more affordable and reliable semaglutide alternative to Hers compounded semaglutide, with a focus on strict quality control in its formulation, ensuring consistent potency and effectiveness without compromising safety
[15] NICE focuses instead on clinical eligibility criteria, monitoring requirements, and the importance of adjunctive lifestyle intervention
Diet, exercise, and adequate protein intake remain essential components of successful treatment